Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.86 +0.03 (+1.64%)
At close: Aug 21, 2026 · 4:00 PM EDT

Tvardi Therapeutics (TVRD) Return on Sales (QoQ) (2013 - 2025)

Tvardi Therapeutics (TVRD) Return on Sales (QoQ) (2013 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Tvardi Therapeutics 17.36 Mn 17.36 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 4.00
Dec 31, 2024 -4.00
Sep 30, 2024 3.00
Jun 30, 2024 7.00
Mar 31, 2024 -4.00
Dec 31, 2023 -5.00
Sep 30, 2023 -1.00
Jun 30, 2023 0.00
Mar 31, 2023 5.00
Dec 31, 2022 -7.00
Sep 30, 2022 -2.00
Jun 30, 2022 6.00
Mar 31, 2022 34.00
Dec 31, 2021 -41.00
Sep 30, 2021 0.00
Jun 30, 2021 12.00
Mar 31, 2021 -13.00
Dec 31, 2020 2.00
Sep 30, 2020 3.00
Jun 30, 2020 -1.00